(Q30477432)

English

Effectiveness of discontinuing antibiotic treatment after three days versus eight days in mild to moderate-severe community acquired pneumonia: randomised, double blind study

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

13 October 2017

Effectiveness of discontinuing antibiotic treatment after three days versus eight days in mild to moderate-severe community acquired pneumonia: randomised, double blind study (English)

1 reference

Europe PubMed Central

PMC publication ID

13 October 2017

1 reference

based on heuristic

inferred from title

Jan-Werner Poley

7

object named as

Jan-Werner Poley

0 references

Patrick Bossuyt

12

object named as

Patrick M M Bossuyt

1 reference

Europe PubMed Central

PMC publication ID

13 October 2017

Marc J. M. Bonten

10

object named as

Marc J M Bonten

1 reference

Europe PubMed Central

PMC publication ID

13 October 2017

14

object named as

Brent C Opmeer

1 reference

Europe PubMed Central

PMC publication ID

13 October 2017

author name string

Rachida el Moussaoui

1

1 reference

Europe PubMed Central

PMC publication ID

13 October 2017

Corianne A J M de Borgie

2

1 reference

Europe PubMed Central

PMC publication ID

13 October 2017

Peterhans van den Broek

3

1 reference

Europe PubMed Central

PMC publication ID

13 October 2017

Willem N Hustinx

4

1 reference

Europe PubMed Central

PMC publication ID

13 October 2017

Paul Bresser

5

1 reference

Europe PubMed Central

PMC publication ID

13 October 2017

Guido E L van den Berk

6

1 reference

Europe PubMed Central

PMC publication ID

13 October 2017

Bob van den Berg

8

1 reference

Europe PubMed Central

PMC publication ID

13 October 2017

Frans H Krouwels

9

1 reference

Europe PubMed Central

PMC publication ID

13 October 2017

Carla Weenink

11

1 reference

Europe PubMed Central

PMC publication ID

13 October 2017

Peter Speelman

13

1 reference

Europe PubMed Central

PMC publication ID

13 October 2017

Jan M Prins

15

1 reference

Europe PubMed Central

PMC publication ID

13 October 2017

language of work or name

0 references

publication date

1 June 2006

1 reference

Europe PubMed Central

PMC publication ID

13 October 2017

1 reference

Europe PubMed Central

PMC publication ID

13 October 2017

332

1 reference

Europe PubMed Central

PMC publication ID

13 October 2017

7554

1 reference

Europe PubMed Central

PMC publication ID

13 October 2017

1355

1 reference

Europe PubMed Central

PMC publication ID

13 October 2017

Revised SWAB guidelines for antimicrobial therapy of community-acquired pneumonia.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1479094

20 June 2018

Outpatient antibiotic use in Europe and association with resistance: a cross-national database study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1479094

20 June 2018

Development and validation of a short questionnaire in community acquired pneumonia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1479094

20 June 2018

Three day versus five day treatment with amoxicillin for non-severe pneumonia in young children: a multicentre randomised controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1479094

20 June 2018

Randomized controlled trial of sequential intravenous (i.v.) and oral moxifloxacin compared with sequential i.v. and oral co-amoxiclav with or without clarithromycin in patients with community-acquired pneumonia requiring initial parenteral treatmen

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1479094

20 June 2018

A European study on the relationship between antimicrobial use and antimicrobial resistance.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1479094

20 June 2018

BTS Guidelines for the Management of Community Acquired Pneumonia in Adults

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1479094

20 June 2018

Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1479094

20 June 2018

Oral moxifloxacin vs high-dosage amoxicillin in the treatment of mild-to-moderate, community-acquired, suspected pneumococcal pneumonia in adults

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1479094

20 June 2018

The Alexander Project 1996-1997: latest susceptibility data from this international study of bacterial pathogens from community-acquired lower respiratory tract infections

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1479094

20 June 2018

Regulating the use of antibiotics in the community

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1479094

20 June 2018

A prediction rule to identify low-risk patients with community-acquired pneumonia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1479094

20 June 2018

Treatment of lobar pneumonia in Papua New Guinea: short course chemotherapy with penicillin or chloramphenicol

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1479094

20 June 2018

One-day treatment for lobar pneumonia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1479094

20 June 2018

Evaluation of new anti-infective drugs for the treatment of respiratory tract infections. Infectious Diseases Society of America and the Food and Drug Administration

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1479094

20 June 2018

High-dose, short-course levofloxacin for community-acquired pneumonia: a new treatment paradigm

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1479094

26 November 2018

A prospective, randomized, double-blind multicenter comparison of parenteral ertapenem and ceftriaxone for the treatment of hospitalized adults with community-acquired pneumonia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1479094

26 November 2018

Efficacy and tolerability of once-daily telithromycin compared with high-dose amoxicillin for treatment of community-acquired pneumonia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1479094

26 November 2018

Clinical efficacy of 3 days versus 5 days of oral amoxicillin for treatment of childhood pneumonia: a multicentre double-blind trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1479094

26 November 2018

A study evaluating the efficacy, safety, and tolerability of ertapenem versus ceftriaxone for the treatment of community-acquired pneumonia in adults

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1479094

26 November 2018

Effect of short-course, high-dose amoxicillin therapy on resistant pneumococcal carriage: a randomized trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1479094

26 November 2018

Low dosage and long treatment duration of beta-lactam: risk factors for carriage of penicillin-resistant Streptococcus pneumoniae.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1479094

26 November 2018

Practice guidelines for the management of community-acquired pneumonia in adults. Infectious Diseases Society of America

1 reference

https://pubmed.ncbi.nlm.nih.gov/16763247

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy and safety of azithromycin versus benzylpenicillin or erythromycin in community-acquired pneumonia

1 reference

https://pubmed.ncbi.nlm.nih.gov/16763247

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. Finnish Study Group for Antimicrobial Resistance

1 reference

https://pubmed.ncbi.nlm.nih.gov/16763247

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A short (3-day) course of azithromycin tablets versus a 10-day course of amoxycillin-clavulanic acid (co-amoxiclav) in the treatment of adults with lower respiratory tract infections and effects on long-term outcome

1 reference

https://pubmed.ncbi.nlm.nih.gov/16763247

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized, multicentre study of the efficacy and tolerance of azithromycin versus clarithromycin in the treatment of adults with mild to moderate community-acquired pneumonia. Azithromycin Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/16763247

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1136/BMJ.332.7554.1355

1 reference

Europe PubMed Central

PMC publication ID

13 October 2017

release_wxwbatwp7rae7pno2jgduy6ycy

1 reference

https://api.fatcat.wiki/v0/release/wxwbatwp7rae7pno2jgduy6ycy

24 November 2022

based on heuristic

mapped directly with Wikidata item

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

13 October 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

13 October 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q30477432&oldid=1978621152"